Abbott Laboratories (ABT) Non-cash Items (2009 - 2022)

Abbott Laboratories has disclosed Non-cash Items across 14 years of filings, most recently posting $23.5 million for Q1 2022.

• Non-cash Items for Q1 2022 came in at $23.5 million, down 98.67% year-over-year; the trailing twelve-month figure through Mar 2022 was $23.5 million (down 98.67% YoY), and the FY2021 annual result was $20.4 million, down 98.69% from the prior year.
• Non-cash Items came in at $23.5 million for Q1 2022 at Abbott Laboratories, up from $20.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $1.8 billion in Q1 2021 to a low of $996.0 in Q4 2018.
• The 5-year median for Non-cash Items is $695.0 million (2018), against an average of $721.9 million.
• Across the five-year window, Non-cash Items plunged 100.0% in 2018 and surged 114256928.11% in 2019, its largest moves.
• Abbott Laboratories' Non-cash Items stood at $996.0 in 2018, then soared by 114256928.11% to $1.1 billion in 2019, then soared by 36.82% to $1.6 billion in 2020, then sank by 98.69% to $20.4 million in 2021, then rose by 15.5% to $23.5 million in 2022.
• The last three Non-cash Items figures came in at $23.5 million (Q1 2022), $20.4 million (Q4 2021), and $1.6 billion (Q3 2021), per Business Quant data.